Extracorporeal Circulation Without Bleeding

See allHide authors and affiliations

Science Translational Medicine  05 Feb 2014:
Vol. 6, Issue 222, pp. 222fs7
DOI: 10.1126/scitranslmed.3008497

You are currently viewing the abstract.

View Full Text


A newly created antibody to the active site of Factor XIIa protects against clotting of extracorporeal bypass circuitry without bleeding risk in vivo, obviating the need for heparin (Larsson et al., this issue).

View Full Text